Form D Explorer

Source evidence

Rgenta Therapeutics, Inc. · 0001231919-26-001529

D filed Nov. 3, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
Woburn
street1
300 TradeCenter, Suite 6600
zipCode
01801
entityName
Rgenta Therapeutics, Inc.
entityType
Corporation
stateOrCountry
MA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold41852307number41852307/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount130107279number130107279/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count9number9/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 7a7008298761339f6b8ac2b912e57948791f2bfe08544a66cdd808db845b63c8. This proves extraction identity, not the accuracy of the filer's claims.